HIV testing and antiretroviral therapy initiation at birth: Views from a primary care setting in Khayelitsha

Southern African Journal of HIV Medicine

Volumn 16, Issue 1, 2015, Pages

  Nelson, Aurélie ^a   Maritz, Jean ^b   Giddy, Janet ^c   Frigati, Lisa ^b   Rabie, Helena ^b   Van Cutsem, Gilles ^a,d   Mutseyekwa, Tabitha ^a   Jange, Nomfusi ^a   Bernheimer, Jonathan ^b   Cox, Mark Cotton Vivian ^a  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c WESTERN CAPE DEPARTMENT OF HEALTH   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NEVIRAPINE; ZIDOVUDINE;

ANTIVIRAL THERAPY; CONJUNCTIVITIS; FOLLOW UP; HIGH RISK INFANT; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTERPERSONAL COMMUNICATION; MOTHER; NEWBORN CARE; PATIENT COUNSELING; PEER GROUP; POLYMERASE CHAIN REACTION; POST EXPOSURE PROPHYLAXIS; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PSYCHOLOGICAL ASPECT; REVIEW; SOCIAL STATUS; STIGMA; VERTICAL TRANSMISSION; VIRAL LOAD TESTING; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 84930860708     PISSN: 16089693     EISSN: 20786751     Source Type: Journal    
DOI: 10.4102/sajhivmed.v16i1.376     Document Type: Review

References (11)

1. Evaluation of the effectiveness of the national PMTCT programme measured at six weeks postpartum in South Africa. Durban: SAPMTCTE study group, MRC, NDOH &PEPFAR/US Centers for Disease Control and Prevention; 2012.
2. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviraltherapy and mortality among HIV-infected infants. N Engl J Med. 2008;359:2233-2244. http://dx.doi.org/10.1056/NEJMoa0800971.
3. Wamalwa D, Benki-Nugent S, Langat A, et al. Survival benefit of early infant antiretroviral therapy is compromised when diagnosis is delayed. Pediatr Infect Dis J. 2012;31:729-731. http://dx.doi.org/10.1097/INF.0b013e3182587796.
4. Persaud D, Palumbo PE, Ziemniak C, et al. Dynamics of the resting CD4(+) T-cell latent HIV reservoir in infants initiating HAART less than 6 months of age. AIDS. 2012;26:1483-1490. http://dx.doi.org/10.1097/QAD.0b013e3283553638.
5. Lilian RR, Kalk E, Technau KG, Sherman GG. Birth diagnosis of HIV infection in infants to reduce infant mortality and monitor for elimination of mother-to-child transmission. Pediatr Infect Dis J. 2013;32:1080-1085. http://dx.doi.org/10.1097/INF.0b013e318290622e.
6. Western Cape Government Department of Health PMTCT clinical guidelines update. Cape Town: Western Cape Department of Health; June 2014.
7. National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV inchildren, adolescents and adults. Pretoria: National Department of Health; December 2014.
8. Gourlay A, Birdthistle I, Mburu G, Iorpenda K, Wringe A. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: A systematic review. J Int AIDS Soc. 2013;16:18588. http://dx.doi.org/10.7448/IAS.16.1.18588.
9. Drake A, Wagner A, Richardson B, John-Stewart G. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: A systematic review and meta-analysis. PLoS Med. 2014;11:e1001608. http://dx.doi.org/10.1371/journal.pmed.1001608.
10. Nuttall JJC. Antiretroviral therapy during the neonatal period. Southern African Journal of HIV Medicine. In press 2015.
11. Scanlon M, Vreeman R. Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings. HIV AIDS (Auckl). 2013;5:1-17.